• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB 2.78% 35.0¢

DIMERIX LIMITED

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing new therapies in areas with unmet medical needs for global markets. It is focused on developing its products, DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its DMX-200 and DMX-700 are identified using its assay, Receptor Heteromer Investigation Technology (Receptor-HIT), which is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. It has completed two Phase 2 studies: one in FSGS and one in diabetic kidney disease. Receptor-HIT is licensed to Excellerate Bioscience.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB
Dimerix (ASX: DXB) Discussion Thread
9 10 11
06/05/24 633 203K
06/05/24 Last post  HOLIDAY1 Comments Created with Sketch.  633  Views Created with Sketch.  203K 
DXB 06/05/24 42 15K
06/05/24 Last post  ExtraPace Comments Created with Sketch.  42  Views Created with Sketch.  15K 
DXB
DXB - Research & Valuation
04/05/24 19 6.5K
04/05/24 Last post  unitfree2 Comments Created with Sketch.  19  Views Created with Sketch.  6.5K 
DXB 02/05/24 72 21K
02/05/24 Last post  BT6487 Comments Created with Sketch.  72  Views Created with Sketch.  21K 
DXB 02/05/24 7 2.0K
02/05/24 Last post  RYNZN Comments Created with Sketch.  7  Views Created with Sketch.  2.0K 
DXB
DXB Media thread.
2 3
01/05/24 127 52K
01/05/24 Last post  NiceRoger Comments Created with Sketch.  127  Views Created with Sketch.  52K 
DXB
News: DXB Dimerix Receives PIP Approval From UK Medicines And Healthcare Products Regulatory Agency
01/05/24 0 126
01/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  126 
DXB 30/04/24 1 526
30/04/24 Last post  kdwc Comments Created with Sketch.  1  Views Created with Sketch.  526 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - DXB
02 May 09:44
 
Dimerix Receives PIP Approval from the UK MHRA
01 May 08:36
 
Application for quotation of securities - DXB
30 Apr 10:00
 
Application for quotation of securities - DXB
22 Apr 11:21
 
Quarterly Appendix 4C and Activities Report
22 Apr 08:45
 
Notification of cessation of securities - DXB
12 Apr 10:26
 
View More arrow Created with Sketch.
(20min delay)
Last
35.0¢
Change
-0.010(2.78%)
Mkt cap ! $192.3M
Open High Low Value Volume
36.0¢ 37.0¢ 34.0¢ $1.977M 5.663M

Buyers (Bids)

No. Vol. Price($)
9 1445485 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 24999 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
34.5¢
  Change
-0.010 ( 4.14 %)
Open High Low Volume
36.5¢ 37.0¢ 34.0¢ 2600347
Last updated 15.59pm 06/05/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.